These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24297530)

  • 21. The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
    Zangenberg M; Grubach L; Aggerholm A; Silkjaer T; Juhl-Christensen C; Nyvold CG; Kjeldsen E; Ommen HB; Hokland P
    Eur J Haematol; 2009 Nov; 83(5):439-48. PubMed ID: 19563517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
    Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.
    Park SH; Chi HS; Shim H; Jang S; Park CJ
    Int J Lab Hematol; 2013 Feb; 35(1):e1-3. PubMed ID: 22978565
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
    Baldus CD; Bullinger L
    Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing.
    Greif PA; Eck SH; Konstandin NP; Benet-Pagès A; Ksienzyk B; Dufour A; Vetter AT; Popp HD; Lorenz-Depiereux B; Meitinger T; Bohlander SK; Strom TM
    Leukemia; 2011 May; 25(5):821-7. PubMed ID: 21339757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracting three-way gene interactions from microarray data.
    Zhang J; Ji Y; Zhang L
    Bioinformatics; 2007 Nov; 23(21):2903-9. PubMed ID: 17921496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FLT3-TKD mutation in childhood acute myeloid leukemia.
    Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Wang LY; Chang WH
    Leukemia; 2003 May; 17(5):883-6. PubMed ID: 12750701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A computational approach for ordering signal transduction pathway components from genomics and proteomics Data.
    Liu Y; Zhao H
    BMC Bioinformatics; 2004 Oct; 5():158. PubMed ID: 15504238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast.
    Pavlova S; Mayer J; Koukalova H; Smardova J
    Int J Oncol; 2003 Jul; 23(1):121-31. PubMed ID: 12792784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic mutation of PHF6 gene in T-cell acute lymphoblatic leukemia, acute myelogenous leukemia and hepatocellular carcinoma.
    Yoo NJ; Kim YR; Lee SH
    Acta Oncol; 2012 Jan; 51(1):107-11. PubMed ID: 21736506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-structure-guided discovery of functional mutations across 19 cancer types.
    Niu B; Scott AD; Sengupta S; Bailey MH; Batra P; Ning J; Wyczalkowski MA; Liang WW; Zhang Q; McLellan MD; Sun SQ; Tripathi P; Lou C; Ye K; Mashl RJ; Wallis J; Wendl MC; Chen F; Ding L
    Nat Genet; 2016 Aug; 48(8):827-37. PubMed ID: 27294619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of cancer common and specific driver gene sets.
    Zhang J; Zhang S
    Nucleic Acids Res; 2017 Jun; 45(10):e86. PubMed ID: 28168295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUFFINN: cancer gene discovery via network analysis of somatic mutation data.
    Cho A; Shim JE; Kim E; Supek F; Lehner B; Lee I
    Genome Biol; 2016 Jun; 17(1):129. PubMed ID: 27333808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mutational landscape of phosphorylation signaling in cancer.
    Reimand J; Wagih O; Bader GD
    Sci Rep; 2013 Oct; 3():2651. PubMed ID: 24089029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell proteomics: potential implications for cancer diagnostics.
    Gavasso S; Gullaksen SE; Skavland J; Gjertsen BT
    Expert Rev Mol Diagn; 2016; 16(5):579-89. PubMed ID: 26895397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces.
    Porta-Pardo E; Garcia-Alonso L; Hrabe T; Dopazo J; Godzik A
    PLoS Comput Biol; 2015 Oct; 11(10):e1004518. PubMed ID: 26485003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets.
    Gao J; Chang MT; Johnsen HC; Gao SP; Sylvester BE; Sumer SO; Zhang H; Solit DB; Taylor BS; Schultz N; Sander C
    Genome Med; 2017 Jan; 9(1):4. PubMed ID: 28115009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of outcome-related driver mutations in cancer using conditional co-occurrence distributions.
    Treviño V; Martínez-Ledesma E; Tamez-Peña J
    Sci Rep; 2017 Feb; 7():43350. PubMed ID: 28240231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating growth patterns and driver effects in tumor evolution from individual samples.
    Salichos L; Meyerson W; Warrell J; Gerstein M
    Nat Commun; 2020 Feb; 11(1):732. PubMed ID: 32024824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.